Abstract
Invention relates to pediatric rheumatology, immunology and hematology and can be used to determine the risk of developing rapidly progressive oligoarthritis
in children. The method consists of detecting genetic markers in the polymorphism
of the PTPN22 gene, specifically the heterozygous CC allele at position 1858.
in children. The method consists of detecting genetic markers in the polymorphism
of the PTPN22 gene, specifically the heterozygous CC allele at position 1858.
Translated title of the contribution | Juvenīla idiopātiska ātri progresējoša oligoartrīta attīstības riska noteikšanas paņēmiens bērniem sešus mēnešus pirms klīnisko pazīmju parādīšanās |
---|---|
Original language | Latvian |
Patent number | 15 269 |
IPC | C12Q1/68,A61P19/02 |
Priority date | 16/05/17 |
Filing date | 16/05/17 |
Publication status | Published - 20 May 2018 |
Keywords*
- risk of developing rapidly progressive oligoarthritis
- children
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 01.12.2020